JuneX Capital Partners - We Back Challengers
JuneX Capital Partners  Launch “Founders Office“ with €100M Evergreen Fund to Back European Entrepreneurs in Human Capital and Investment Management
April 24, 2024 02:59 ET | JuneX Capital Partners GP
Press release Sophia Antipolis, London, April 24rd, 2024   JuneX Capital Partners Launch “Founders Office“with €100M Evergreen Fundto Back European Entrepreneursin Human Capital and Investment...
Logo.jpg
Clean Energy Technologies Signs MOU with International Private Equity Fund
April 18, 2024 09:29 ET | Clean Energy Technologies, Inc.
COSTA MESA, CA., April 18, 2024 (GLOBE NEWSWIRE) -- Clean Energy Technologies, Inc. (Nasdaq: CETY) (“CETY” or the “Company”), a clean energy manufacturing and services company, offering eco-friendly...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces $55 Million Debt Facility
April 18, 2024 09:15 ET | Sanara MedTech Inc.
FORT WORTH, TX, April 18, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
Making Space Wins Inaugural WGU Labs Accelerator Pitch Competition
WGU Labs Announces Making Space as the Winner in Inaugural Accelerator Competition in EdTech Innovations
April 16, 2024 14:42 ET | Western Governors University
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- WGU Labs, a leader in accelerating education innovation, today announced Making Space as the winner of its inaugural Accelerator Pitch Competition. The...
boehringer_biopharmaceutical production_Biberach resized
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
April 16, 2024 04:35 ET | Boehringer Ingelheim
Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV®Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8...
ocugen_4C_LOGO (002).png
Ocugen Provides Business Update with Certain Financials for the Year Ending 2023
April 02, 2024 08:00 ET | Ocugen
Received alignment with FDA for broad retinitis pigmentosa (RP) indication in Phase 3 clinical trial of OCU400—first gene therapy program to receive a broad indication for RP. OCU400 Phase 3 clinical...
Origional Logo_Violet_2022.png
AppTech Payments Corp. Reports Fiscal Year 2023 Results
April 01, 2024 16:15 ET | AppTech Corp.
CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (NASDAQ: APCX), a pioneering Fintech company powering frictionless commerce, disclosed its financial outcomes for the...
Defiance ETFs Announces Monthly Distributions
**Defiance ETFs Announces Monthly Distributions on $QQQY (56.94%), $JEPY (37.52%), $IWMY (72.30%), $TRES (11.50%), and $SPYT
March 27, 2024 20:28 ET | Defiance ETFs
Defiance ETFs Announces Monthly Distributions on $QQQY (56.94%), $JEPY (37.52%), $IWMY (72.30%), $TRES (11.50%), and $SPYT.
OREZONE_LOGO_Horizontal_Colour.jpg
Orezone Reports 2023 Year-end and Q4 Results, and Provides 2024 Guidance
March 26, 2024 18:44 ET | Orezone Gold Corporation
VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) reported its operational and financial results for the...
OREZONE_LOGO_Horizontal_Colour.jpg
Orezone Provides Notice of 2023 Year-End Results and 2024 Guidance
March 21, 2024 11:00 ET | Orezone Gold Corporation
VANCOUVER, British Columbia, March 21, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone”) will announce its 2023 year-end and fourth quarter results along with...